Gene Amplification Technologies - Global Strategic Business Report: Capture $4.4B in New Revenue by 2030 as Abbott, Bio-Rad, bioMerieux, Cepheid and Becton Dickinson Battle for Share
Dublin, Nov. 10, 2026 (GLOBE NEWSWIRE) -- "Gene Amplification Technologies - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global gene amplification technologies market, valued at US$5.7 billion in 2024, is projected to reach US$10.1 billion by 2030. This represents a compound annual growth rate of 10% between 2024 and 2030. Market expansion is being supported by rising demand for molecular diagnostics, personalized medicine, genetic testing and advanced biomedical research.
The latest gene amplification technologies market report provides an in-depth assessment of industry trends, growth drivers, competitive conditions and regional opportunities. It also evaluates recent global tariff developments and their potential effects on supply chains, sourcing strategies, operating costs and geographic market realignment.
Technology Innovation Expands Market Opportunities
Continuous innovation is improving the precision, scalability and efficiency of gene amplification technologies. Real-time polymerase chain reaction and digital polymerase chain reaction systems are strengthening quantitative genetic analysis, while next-generation sequencing platforms support the simultaneous processing of large numbers of DNA fragments. These capabilities are accelerating genomic research, biomarker discovery and clinical testing.
CRISPR-based methods are also creating opportunities in targeted gene editing, gene regulation and therapeutic development. As laboratories and healthcare organizations seek faster and more accurate analytical platforms, technology providers are focusing on workflow automation, higher throughput, improved sensitivity and cost-efficient testing.
Clinical Diagnostics and Precision Medicine Drive Adoption
Medical and pharmaceutical applications represent a major source of market growth. Gene amplification technologies are increasingly used to detect pathogenic infections, cancer-associated mutations and inherited genetic disorders. Their role in early diagnosis and treatment selection is becoming more important as precision medicine strategies gain wider adoption.
Pharmaceutical and biotechnology companies also use these technologies to identify therapeutic targets, evaluate drug candidates and support safety and efficacy testing. Rising cancer incidence, growing awareness of genetic disorders and expanding investment in genomic research are expected to sustain demand through 2030.
Applications extend beyond healthcare. Forensic and identity testing laboratories rely on gene amplification for genetic analysis, while agricultural and food safety organizations use these platforms in crop research, pathogen detection and quality assurance. Environmental research applications include biodiversity assessment and microbial population monitoring.
Market Segment and Regional Outlook
Domain Expert Insights
The report tracks the influence of precision medicine, genomic research funding, healthcare investment and regulatory support on market development. It also examines how advances in molecular diagnostics and genetic analysis are reshaping competitive strategies across healthcare, pharmaceuticals, biotechnology, agriculture and forensic science.
Domain specialists identify accuracy, accessibility and cost efficiency as important factors supporting adoption. Government-backed genomic initiatives, research grants and healthcare programs are further expanding access to advanced testing technologies. At the same time, changing trade policies and tariff negotiations may affect instrument manufacturing, reagent sourcing, international distribution and supplier relationships.
The analysis incorporates global tariff negotiations involving more than 180 countries, with particular attention to supply chain disruption and trade tensions that intensified during 2025. Revised forecasts through 2030 account for tariff effects, economic uncertainty and structural changes in globalization. Historical market analysis covering 2015 through 2023 provides additional context for long-term trends.
Competitive Landscape
The report assesses 52 companies active in the global gene amplification technologies market. Featured participants include:
Report Coverage and Business Value
The gene amplification technologies market report presents independent annual sales estimates and forecasts in US$ million from 2024 through 2030. It analyzes the medical and pharmaceutical, forensic and identity testing, agricultural and food safety, and other application segments.
Coverage includes regional market performance, company profiles, technology trends, product and process innovation, competitive positioning and updated 2025 market share estimates. Companies are assessed according to their market presence, including strong, active, niche and limited competitive positions.
The report helps decision-makers evaluate market growth, identify emerging revenue opportunities and understand the factors influencing demand through 2030. It addresses expected changes in regional and segment shares, leading companies' prospects, market restraints, trade-related risks and the technologies likely to shape the future of gene amplification.
Purchasers also receive complimentary report updates for one year, providing continued access to significant market, competitive, economic and regulatory developments.
Key Attributes:
For more information about this report visit https://www.researchandmarkets.com/r/k8b58a
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.